Centene Corporation (NYSE:CNC ) Q2 2025 Earnings Conference Call July 25, 2025 8:30 AM ET Company Participants a - Corporate Participant v - Corporate Participant Andrew Lynn Asher - Chief Financial Officer Jennifer Lynch Gilligan - Senior Vice President of Investor Relations Sarah M. London - CEO & Director Conference Call Participants Albert J.
CNC reports rare Q2 loss amid surging medical costs, lower investment and other income despite strong revenue growth.
Centene Corp (NYSE:CNC) stock is 3.9% higher to trade at $27.75 this morning, even after the managed healthcare company reported an adjusted second-quarter loss of 16 cents per share, steeper than the 11 cents per share projected.
Centene (CNC) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of $0.68. This compares to earnings of $2.42 per share a year ago.
Health insurer Centene reported a $253 million loss in its second quarter as the provider of government-subsidized benefits struggles to manage costs of its health plan members.
Centene's stock extends its record monthly selloff after the health insurer reported a surprise quarterly loss as benefit payouts exceed expectations.
The company reported a surprise quarterly loss, the latest blow for the embattled health insurance industry.
Centene on Friday reported a surprise quarterly loss after the health insurer warned of a revenue slump from government-backed plans, sending its shares down nearly 3% in premarket trading.
Centene Corporation ( CNC ), a giant of managed care expected to cross $175 billion in revenues this year, unexpectedly pulled its earnings guidance for 2025 on July 2. This change came after an unexpected shift in the dynamics of the health Insurance Marketplace, which could impact earnings more significantly than what was initially forecasted.
CNC's Q2 earnings are likely to have felt the pinch as rising medical costs pressure margins despite higher premium revenues.
Evaluate the expected performance of Centene (CNC) for the quarter ended June 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
CNC is trading at half of book value and under 9x earnings, an extreme undervaluation for a cash-generating insurer. The recent guidance cut is a temporary earnings reset, not a structural issue -- premium increases and cost controls will restore margins as per standard industry cycles. Market panic and mechanical selling have created a rare value opportunity; insurance fundamentals and rate adjustments ensure earnings normalization over time.